Privia Health Group

Privia Health Group, Inc. engages in the provision of healthcare services. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experience, and reward doctors for delivering care both in-person and via its Privia Platform, virtual care settings. The company was founded by Jeffrey Butler on November 7, 2007 and is headquartered in Arlington, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Privia Health Group reports robust Q1 performance and growth outlook

Privia Health Group delivered strong financial performance in Q1 2023, with growth in key metrics and a reaffirmation of guidance.
The company faces challenges in maintaining value-based care penetration and addressing analyst inquiries on market performance.
However, Privia Health's strategic focus on expansion, performance improvement, and shared savings generation presents promising opportunities.
Overall, Privia Health's resilience, growth trajectory, and strategic initiatives position them well for future success in the healthcare industry.

Privia Health Group reports robust Q2 growth and strategic expansion

Privia Health Group's Q2 performance reflects strong financial growth, operational stability, and strategic expansion into new markets and care models.
While facing challenges such as increased AR and market entry costs, the company's focus on value-based care and operational optimization positions it for long-term success.
With a robust leadership team, steady provider retention, and a clear growth strategy, Privia is well-positioned to capitalize on opportunities in value-based care and market expansion.

Privia Health Group excels in Q3, poised for growth

Privia Health Group's Q3 performance reflects robust growth in providers, patients, and financial metrics, underpinning its competitive strength and market positioning.
While facing challenges in maintaining growth rates and managing diverse healthcare segments, Privia's strategic focus on expansion and innovation presents growth opportunities.
With a solid financial foundation, innovative business model, and optimistic outlook, Privia is poised for continued success and value creation in the healthcare industry.

Privia Health Group excels in 2023, eyes growth amid challenges

Privia Health Group's strong financial performance, stable cash position, and strategic focus on growth and profitability position it well for future success.
While facing challenges in managing value-based risk arrangements and revenue declines from renegotiated contracts, Privia is adapting and pursuing growth opportunities.
With a solid patient base, prudent financial management, and a clear growth strategy, Privia is navigating market challenges and aiming for continued success in 2024.

Privia Health Group reports robust Q1 performance and eyes growth

Privia Health Group's Q1 2024 performance reflects strong growth and profitability, supported by a robust balance sheet and strategic focus on primary care-centric networks. While facing challenges from certain market exits, the company is well-positioned to capitalize on opportunities in risk arrangements and program enhancements for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Privia Health Group, Inc. (NASDAQ:PRVA ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President- Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Andrew Mok - Barclays Richard Close - Canaccord Genuity Jailendra Singh - Truist Securities Jamie Perse - Goldman Sachs Sameer Patel - Evercore ISI Matthew Gillmor - KeyBanc David Larsen - BTIG Jeff Garro - Stephens Ryan Langston - TD Cowen Daniel Grosslight - Citi Olivia Miles - Baird Jack Slevin - Jeffries Jessica Tassan - Piper Sandler Thomas Kelliher - RBC Capital Markets Adam Ron - Bank of America Operator Thank you for standing by.

Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call Transcript

While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Compared to Estimates, Privia Health (PRVA) Q3 Earnings: A Look at Key Metrics

Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago.

Privia Health (PRVA) Misses Q3 Earnings Estimates

ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024.

Privia Health Reports Third Quarter 2024 Financial Results

Privia Health (PRVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Privia Health (PRVA) Earnings Expected to Grow: Should You Buy?

Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program; $176.6M in Shared Savings Delivered Across 10 Participating ACOs

Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program

Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2024 Earnings Conference Call August 8, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President, Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Josh Raskin - Nephron Research Andrew Mok - Barclays Eduardo Ron - Truist Securities Elizabeth Anderson - Evercore ISI A.J. Rice - UBS Jeff Garro - Stephens Jack Slevin - Jefferies David Larsen - BTIG Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler Ryan Daniels - William Blair Michael Hall - Baird Ryan Langston - TD Cowen Daniel Grosslight - Citi Adam Ron - Bank of America Operator Hello, and thank you for standing by.

Privia Health Group, Inc. (PRVA) Q2 2024 Earnings Call Transcript

Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Here's What Key Metrics Tell Us About Privia Health (PRVA) Q2 Earnings

Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.

Privia Health (PRVA) Lags Q2 Earnings Estimates

ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six months ended June 30, 2024.

Privia Health Reports Second Quarter 2024 Financial Results

Privia Health (PRVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Privia Health (PRVA) Q2 Earnings Expected to Decline

ARLINGTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present at the 44th Annual William Blair Growth Stock Conference on Wednesday, June 5, 2024, beginning at 11:00 am ET / 10:00 am CT.

Privia Health to Participate in the William Blair Growth Stock Conference

ProFrac Holding Corp

Allogene Therapeutics Inc

Shift4 Payments

MCBC Hlds

Vestis Corp

With the earnings-reporting season winding down, the windows for making insider purchases are opening up.

Insider Buying of These 6 Stocks Surges: Fracking, Boats, a Buyout Candidate

Definitive Healthcare Corp

Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now?

DH or PRVA: Which Is the Better Value Stock Right Now?

Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2024 Earnings Conference Call May 9, 2024 8:00 AM ET Company Participants Robert Borchert – Senior Vice President-Investor and Corporate Communications Parth Mehrotra – Chief Executive Officer David Mountcastle – Chief Financial Officer Conference Call Participants A.J. Rice – UBS Sameer Patel – Evercore ISI Joshua Raskin – Nephron Research David Larsen – BTIG Richard Close – Canaccord Genuity Andrew Mok – Barclays Jeff Garro – Stephens Jack Slevin – Jefferies Jess Tassan – Piper Sandler Ryan Daniels – William Blair Whit Mayo – Leerink Partners Jailendra Singh – Truist Daniel Grosslight – Citi Adam Ron – Bank of America Operator Welcome to the Privia Health First Quarter 2024 Conference Call.

Privia Health Group, Inc. (PRVA) Q1 2024 Earnings Call Transcript

The headline numbers for Privia Health (PRVA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Here's What Key Metrics Tell Us About Privia Health (PRVA) Q1 Earnings

Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.

Privia Health (PRVA) Misses Q1 Earnings and Revenue Estimates

Practice Collections +7.4% compared to 1Q'23 Implemented Providers +17.3% compared to 1Q'23 Company Reiterated Full Year 2024 Guidance ARLINGTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2024.

Privia Health Reports First Quarter 2024 Financial Results

ARLINGTON, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2024 before market open on Thursday, May 9, 2024.

Privia Health to Report First Quarter 2024 Results on Thursday, May 9

Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2023 Earnings Conference Call February 27, 2024 8:00 AM ET

Privia Health Group, Inc. (PRVA) Q4 2023 Earnings Call Transcript

Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Privia Health (PRVA) Reports Q4 Earnings: What Key Metrics Have to Say

Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.14 per share a year ago.

Privia Health (PRVA) Misses Q4 Earnings Estimates

Achieved All 2023 Operating and Financial Guidance Metrics Implemented Providers +19.4% compared to Year-End 2022 Introduces Full-Year 2024 Guidance Proactive Steps to Limit Downside Risk Arrangements in Current Medicare Advantage Environment for More Favorable Contract Structures and Margin Contribution ARLINGTON, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2023.

Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results

ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth.

Privia Health Appoints Edward C. Fargis as General Counsel

ARLINGTON, Va., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its fourth quarter and full year ended December 31, 2023 before market open on Tuesday, February 27, 2024.

News for Privia Health Group Stock (PRVA)